Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
March 11, 2024 08:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix...
Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum
October 25, 2023 07:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it will be unveiling the new brand for its...
Skin Grafting System Market Size Worth $1.34Bn, Globally, by 2028 at 7.1% CAGR - Exclusive Report by The Insight Partners
April 29, 2022 06:16 ET
|
The Insight Partners
New York, April 29, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Skin Grafting System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Wound Closure Devices Market to Surpass USD 22 Billion and Expected to Witness a CAGR of 7.40% by 2026 | DelveInsight
February 04, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Wound Closure Devices Market to Surpass USD 22 Billion and Expected to Witness a CAGR of 7.40% by 2026 | DelveInsight As per DelveInsight...
ROSEN, A RESPECTED AND LEADING FIRM, Encourages PolarityTE, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – PTE
September 29, 2021 16:08 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
RenovaCare Clinical Trial to Start at U.S. Burn Centers
June 07, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United...
Merakris Therapeutics, Inc. Announces FDA Clearance for Dermacyte® Liquid Clinical Trial
May 25, 2021 09:00 ET
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Merakris Therapeutics, Inc. (Merakris) announced that it has received U.S. Food and Drug Administration (FDA) clearance for a Phase II...
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
February 25, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
December 22, 2020 08:00 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
November 19, 2020 08:15 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...